In vivo, in a xenograft mouse model, DHPO treatment significantly reduced tumor volume without observable signs of systemic toxicity, suggesting that USP7 functions as a ferroptosis regulator and may represent a promising therapeutic target (82). This evidence concerns the gene USP7 and neoplasm.